Corporate Membership

Join Us

Elevate Your Brand and Succeed with ACT

ACT maintains a highly visible, well-regarded presence in the toxicology community through educational programs, professional networking opportunities, and our scientific journal.

Corporate support is essential to the continued success of the College and the achievement of its goals, and the ACT corporate membership program is a highly visible way for companies with a vested interest in the field of toxicology to show their support for the vital work of the College. In return, ACT corporate members benefit by elevating their brand and credibility as an ACT partner.

Why Join Forces with ACT?

ACT is a leader in toxicology education, offering well-regarded resources:

  • Signature Webinars
  • ToxChats Podcasts
  • Education Courses
  • eLearning Seminars
  • Annual Meeting—CE Courses, Symposia, Exhibition
  • International Journal of Toxicology

Who We Are and Who You Reach

ACT members are professional scientists, postdocs, and students representing:

  • Pharmaceutical and Biotech Industries
  • Contract Research Organizations
  • Regulatory Agencies
  • Academia
  • Consulting Firms

Corporate Membership Packages

Choose from two distinct packages to elevate your brand and maximize your reach.

Corporate Partner ($3,500 per Year):

  • Five job postings for six months each ($1,250 value)
  • Enhanced listing with hyperlink in the quarterly membership Newsletter
  • Enhanced listing with your logo in an issue of International Journal of Toxicology
  • Recognition in the Program and on signage at the ACT Annual Meeting
  • One blog post with your unique content in the ACTalks blog
  • One additional Exhibitor Priority Point for companies that also exhibit at the Annual Meeting, and Priority exhibit booth selection at the Annual Meeting
  • Logo on the ACT website home page
  • ACT Corporate Member logo for use on your company website
  • Enhanced listing on the ACT website with your logo, company description (50 words), and hyperlink to your company’s website

Corporate Contributor ($1,500 per Year):

  • Two job postings for six months each ($500 value)
  • Listing of company name in the quarterly membership Newsletter
  • Listing of company name in an issue of International Journal of Toxicology
  • Listing of company name with hyperlink on the ACT website
  • Recognition in the Program and on signage at the ACT Annual Meeting
  • Priority exhibit booth selection at the Annual Meeting in November

To take advantage of ACT Corporate Membership, please contact Liz Kasabian, 703.547.0875 ext. 1437.

2021 Corporate Members

ACT Corporate Members provide a sustained and important contribution to our success with their financial contributions, helping ACT pursue key strategic initiatives and deliver timely educational programs.

Corporate Partners

Altascience Logo

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

Learn more | Contact
Amplify Logo

AmplifyBio combines the strength and experience of our multi-disciplinary teams to advance translational science, cell and gene therapies and next-generation medicines for novel treatment advances, cutting-edge technologies, and new research frontiers.

Learn more
 Biomere Logo

Biomere is a global, nonclinical contract research organization (CRO) with locations on the east and west coast, as well as multiple locations in China (JOINN). Our globality, personal approach and our drive to expedite research timelines, makes us ideally suited to support our clients’ needs.

Learn more | Contact
Charles River Logo

Charles River has an industry leading network of scientific experts, setting the bar for robust safety assessment of drugs, devices and chemicals. Experience with countless molecules and regulations allows us to mitigate risk and expedite development, saving time and money on the road to approval.

Learn more
inotiv Logo

In choosing a laboratory partner for discovery and development, Expect More: more attention, insight and a superlative experience. Inotiv delivers a comprehensive and integrated range of right-size in vivo discovery and tox services, BioA, pathology, DMPK and consulting solutions essential to your success.

Learn more | Contact
Labcorp Logo

Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident. Click below to learn more about Labcorp and follow us on LinkedIn and Twitter @Labcorp.

Learn more | Contact
Lilly Logo

Lilly unites caring with discovery to create medicines that make life better for people around the world.

Learn more
Lovelace Logo

Lovelace Biomedical is a preclinical contract research organization conducting research to advance pharmaceutical and biotechnology companies in their complex drug development studies. For over 70 years, Lovelace has leveraged its multidisciplinary expertise in toxicology, gene therapy, infectious disease, medical countermeasures and more.

Learn more
 Noble Life Sciences Logo

Noble Life Sciences is a preclinical CRO owned and operated by scientists with decades of experience in drug, vaccine, and device development. We offer GLP and non-GLP services- animal models, PK/PD, safety, toxicology, and cell-based assays with a strong focus on oncology and infectious diseases.

Learn more
Pfizer Logo

Pfizer is one of the world’s premier biopharmaceutical companies, that brings therapies to people to extend and significantly improve their lives. At Pfizer, we strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products.

Learn more
Regeneron Logo

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Our unique ability to consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates to help patients.

Learn more

Corporate Contributors

BD (Becton, Dickinson and Company)
Learn more
Learn more
Boehringer Ingelheim Pharmaceuticals, Inc.
Learn more
Learn more
Genentech, Inc.
Learn more
Gilead Sciences, Inc.
Learn more
ITR Laboratories Canada Inc.
Learn more
Sanofi U.S.
Learn more
SenzaGen AB
Learn more
Takeda Pharmaceutical International Co.
Learn more